|
|
Volumn 13, Issue 6, 2002, Pages 903-909
|
|
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: A multicenter dose-finding study in women with breast cancer
a
|
|
Author keywords
Breast cancer; Chemotherapy; Filgrastim; Neutropenia; Pegylation; Phase II clinical trial
|
|
Indexed keywords
DOCETAXEL;
DOXORUBICIN;
MACROGOL;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
PACLITAXEL;
TAXOID;
ADULT;
ANTIBODY PRODUCTION;
ARTICLE;
AUTOREGULATION;
BONE PAIN;
BREAST CANCER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
FEMALE;
HUMAN;
LEUKOCYTE COUNT;
MAJOR CLINICAL STUDY;
NEUTROPENIA;
NEUTROPHIL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
COMPARATIVE STUDY;
CONFIDENCE INTERVAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG TOXICITY;
FOLLOW UP;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
PROBABILITY;
REFERENCE VALUE;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT OUTCOME;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
COMPARATIVE STUDY;
CONFIDENCE INTERVALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
DRUG TOXICITY;
FEMALE;
FILGRASTIM;
FOLLOW-UP STUDIES;
HUMAN;
INJECTIONS, SUBCUTANEOUS;
MIDDLE AGE;
NEUTROPENIA;
PACLITAXEL;
PROBABILITY;
REFERENCE VALUES;
SUPPORT, NON-U.S. GOV'T;
TREATMENT OUTCOME;
HUMANS;
MIDDLE AGED;
TAXOIDS;
|
|
EID: 0035990090
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdf130 Document Type: Article |
|
Times cited : (282)
|
|
References (8)
|
